chronic kidney disease

FDA approved stamp regulations yes go
Pharma

Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes

Kerendia was approved to reduce a key risk factor for CKD progression in patients with type 1 diabetes.
Donavyn Coffey Sep 17, 2026 2:06pm
Human kidney anatomy

Vera’s strong ph. 3 Trutakna data intensify IgAN rivalry

Sep 16, 2026 2:50pm
Doctor diagnoses kidney

In a first, Otsuka’s Voyxact stabilizes IgAN kidney loss in ph.3

Aug 3, 2026 5:00pm
Human kidney anatomy

Vera’s dual-target atacicept wins FDA approval for IgAN

Jul 7, 2026 12:23pm
Ultomiris

AZ's Ultomiris hits goal in ph. 3 IgAN trial

Apr 21, 2026 10:35am
Bayer

Bayer tees up Kerendia for major CKD label expansion

Mar 16, 2026 9:46am